AD is a heterogenous disorder characterized clinically by apraxia, aphasia, and agnosia and neuropathologically by the presence of β-amyloid plaques and hyperphosphorylated tau tangles [2, 3]. The gene discussed is MAPT; the disease is Alzheimer disease.